Dr. Fernandez Discusses Immunotherapy Plus Radiation Therapy for Prostate Cancer
Eduardo Fernandez, MD, PhD, FACRO, Senior Vice President, Medical Affairs / Medical Director for Latin America, Radiation Oncologist, 21st Century Oncology, discusses the potential for immunotherapy and radiation therapy to be used together to treat prostate cancer.
Eduardo Fernandez, MD, PhD, FACRO, Senior Vice President, Medical Affairs / Medical Director for Latin America, Radiation Oncologist, 21st Century Oncology, discusses the potential for immunotherapy and radiation therapy to be used together to treat prostate cancer.
Fernandez says the role that immunotherapy plays when combined with radiation therapy is finally starting to be understood. Researchers know now that radiation therapy triggers an immune response. By enhancing the immune response, radiation therapy can also be enhanced, Fernandez says.
Sipuleucel-T (Provenge) activates the immune system against the prostate cancer cells. While sipuleucel-T has demonstrated benefit, researchers are looking to further these benefits by combining it with radiation. ​
